Liraglutide, initiated at 0.6 mg per day, was escalated to the maximum tolerated dose or up to 3.0 mg per day over 4 weeks
Our lab operates in compliance with Coalition for Compounding Excellence (CCE) accreditation standards and applicable USP guidelines
TRIUMPH-1 (80 Weeks) The pivotal TRIUMPH-1 obesity trial (2,339 adults, no diabetes), presented at ADA 2026, extended the treatment window to 80 weeks and produced the largest pivotal weight-loss readout to date: Among the 12 mg group, 45.3% lost at least 30% of their body weight and 65.3% ended the trial with a BMI below 30
How retatrutide works differently than other weight loss peptides Understanding the dosage chart requires understanding what retatrutide actually does inside your body
Contact us today to learn more about GLP-1 and our weight loss programs featuring semaglutide, tirzepatide, and other options
Zhang, R., Xu, L., and Dong, C., Protein Peptide Lett